Search research articles
Contact Us
Filters
Showing results (121-130 of 199) with videos related to
Page
of 20
Sort By:
Clinical Epigenetics
|
April 29, 2023
A study of using epigenetic modulators to enhance response to pembrolizumab (MK-3475) in microsatellite stable advanced colorectal cancer
Marina Baretti, Adrian G Murphy, Marianna Zahurak, et al.
World Journal of Surgery
|
June 22, 2019
Readmission Adversely Affects Survival in Surgical Rectal Cancer Patients
Sophia Y Chen, Miloslawa Stem, Susan L Gearhart, et al.
Oncotarget
|
February 20, 2016
A new immunohistochemistry prognostic score (IPS) for recurrence and survival in resected pancreatic neuroendocrine tumors (PanNET)
Antonio Viúdez, Filipe L F Carvalho, Zahra Maleki, et al.
Nature Reviews. Cancer
|
August 29, 2019
An analysis of genetic heterogeneity in untreated cancers
Johannes G Reiter, Marina Baretti, Jeffrey M Gerold, et al.
JCI Insight
|
March 22, 2019
PD-L1 expression and tumor mutational burden are independent biomarkers in most cancers
Mark Yarchoan, Lee A Albacker, Alexander C Hopkins, et al.
Cancer Immunology Research
|
May 3, 2019
Programmed Cell Death Ligand-1 (PD-L1) and CD8 Expression Profiling Identify an Immunologic Subtype of Pancreatic Ductal Adenocarcinomas with Favorable Survival
Ludmila Danilova, Won Jin Ho, Qingfeng Zhu, et al.
American Journal of Clinical Oncology
|
June 14, 2022
Nonoperative Management Following Complete Response in Rectal Cancer After Short-course Radiation Therapy and Consolidation Chemotherapy: Clinical Outcomes and Quality of Life Measures
Abhinav V Reddy, Bashar Safar, Angela Y Jia, et al.
Oncotarget
|
April 15, 2017
Correction: A new immunohistochemistry prognostic score (IPS) for recurrence and survival in resected pancreatic neuroendocrine tumors (PanNET)
Antonio Viúdez, Filipe L F Carvalho, Zahra Maleki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 21, 2009
Hand-foot skin reaction increases with cumulative sorafenib dose and with combination anti-vascular endothelial growth factor therapy
Nilofer S Azad, Jeanny B Aragon-Ching, William L Dahut, et al.
Hepatology Communications
|
February 19, 2025
Deep immune profiling of intrahepatic cholangiocarcinoma with CODEX multiplexed imaging
Marina Baretti, Soumya Shekhar, Vaibhav Sahai, et al.
Page
of 20
Search research articles
Search
Showing results (121-130 of 199) with videos related to
Sort By:
Page
of 20
Clinical Epigenetics
|
April 29, 2023
A study of using epigenetic modulators to enhance response to pembrolizumab (MK-3475) in microsatellite stable advanced colorectal cancer
Marina Baretti, Adrian G Murphy, Marianna Zahurak, et al.
World Journal of Surgery
|
June 22, 2019
Readmission Adversely Affects Survival in Surgical Rectal Cancer Patients
Sophia Y Chen, Miloslawa Stem, Susan L Gearhart, et al.
Oncotarget
|
February 20, 2016
A new immunohistochemistry prognostic score (IPS) for recurrence and survival in resected pancreatic neuroendocrine tumors (PanNET)
Antonio Viúdez, Filipe L F Carvalho, Zahra Maleki, et al.
Nature Reviews. Cancer
|
August 29, 2019
An analysis of genetic heterogeneity in untreated cancers
Johannes G Reiter, Marina Baretti, Jeffrey M Gerold, et al.
JCI Insight
|
March 22, 2019
PD-L1 expression and tumor mutational burden are independent biomarkers in most cancers
Mark Yarchoan, Lee A Albacker, Alexander C Hopkins, et al.
Cancer Immunology Research
|
May 3, 2019
Programmed Cell Death Ligand-1 (PD-L1) and CD8 Expression Profiling Identify an Immunologic Subtype of Pancreatic Ductal Adenocarcinomas with Favorable Survival
Ludmila Danilova, Won Jin Ho, Qingfeng Zhu, et al.
American Journal of Clinical Oncology
|
June 14, 2022
Nonoperative Management Following Complete Response in Rectal Cancer After Short-course Radiation Therapy and Consolidation Chemotherapy: Clinical Outcomes and Quality of Life Measures
Abhinav V Reddy, Bashar Safar, Angela Y Jia, et al.
Oncotarget
|
April 15, 2017
Correction: A new immunohistochemistry prognostic score (IPS) for recurrence and survival in resected pancreatic neuroendocrine tumors (PanNET)
Antonio Viúdez, Filipe L F Carvalho, Zahra Maleki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 21, 2009
Hand-foot skin reaction increases with cumulative sorafenib dose and with combination anti-vascular endothelial growth factor therapy
Nilofer S Azad, Jeanny B Aragon-Ching, William L Dahut, et al.
Hepatology Communications
|
February 19, 2025
Deep immune profiling of intrahepatic cholangiocarcinoma with CODEX multiplexed imaging
Marina Baretti, Soumya Shekhar, Vaibhav Sahai, et al.
Page
of 20